Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Embla Medical – A look back at 2024 with CEO

By Michael FriisHead of Equities
Embla Medical

With a share price return of +30%, Embla Medical has outperformed both the Danish stock market and the European Medtech sector. Together with Embla Medical’s CEO Sveinn Solvason, we looked back at the main achievements in 2024 and the key drivers behind the results.

In the interview, you can hear more about the main headlines for Embla Medical, how 2024 has positioned the company to deliver on the 2027 strategy, and lastly which milestones investors should look out for in 2025.

Disclaimer: HC Andersen Capital receives payment from Embla Medical for a Corporate Visibility/Digital IR subscription agreement. /Michael Friis, 09:26, 06-12-2024.

Recent videos

Easor, Webcast, Q4'25
11.03.2026, 11.30 Easor
Merus Power: Growth story with profitable direction in sight
11.03.2026, 11.27 Merus Power
Talenom, Webcast, Financial Statements Release for 2025
11.03.2026, 10.00 Talenom
HCA Morgenbørs 11/03 - Fortsat fokus på Mellemøsten og inflationstal fra USA senere i dag
11.03.2026, 09.27 Torm
Clas Ohlson, Audiocast, Q3'26
11.03.2026, 09.00 Clas Ohlson
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.